|Articles|September 27, 1995

Siemens taps Weatherhead as marketing VP

Nuclear medicine veteran Randy Weatherhead has been named vicepresident of marketing for the nuclear medicine division of SiemensMedical Systems in Hoffman Estates, IL. Weatherhead fills a positionpreviously held by Robert Lytle, who died in a plane

Nuclear medicine veteran Randy Weatherhead has been named vicepresident of marketing for the nuclear medicine division of SiemensMedical Systems in Hoffman Estates, IL. Weatherhead fills a positionpreviously held by Robert Lytle, who died in a plane crash earlierthis year (SCAN 5/10/95).

Weatherhead joins Siemens after a two-year stint with ADACLaboratories, where he was senior marketing manager. Prior toADAC, he was vice president of marketing at Sopha Medical Systems.

Weatherhead said his goal at Siemens is to grow the nucleardivision's market share, which stands at 21% globally. He seesthe company's investments in detector technology and computerworkstations as particularly important.

"We have an extensive distribution system worldwide, withthe largest service organization of any nuclear medicine company,"Weatherhead said. "We should be able to increase our marketshare substantially over the next few years."


Related to this article

Does kV Still Matter in Photon-Counting CT?
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
CT Radiation Dosing: Where Things Stand, Part 2
In the second of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed future directions for research on CT radiation dosing, including the potential of indication-specific diagnostic reference levels (DRLs).
CT Radiation Dosing: Where Things Stand, Part 1
In the first of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed recently published research showing significant declines in computed tomography (CT) radiation dosing over the past decade.